IRFAN AHMED: Open Payments
NPI 1740409333 · TOLEDO, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$25,425 in 176 payments from 19 companies in 2025. Trend: 2023 $31,865 · 2024 $39,468 · 2025 $25,425
Speaker / faculty: $20,507Food & beverage: $3,113Travel & lodging: $1,805
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 42 | $23,124 |
| ABBVIE INC. | 18 | $337 |
| Neurocrine BioSciences, Inc. | 13 | $270 |
| Teva Pharmaceuticals USA, Inc. | 13 | $261 |
| E.R. Squibb & Sons, L.L.C. | 7 | $208 |
| Lundbeck LLC | 18 | $207 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 17 | $180 |
| Janssen Pharmaceuticals, Inc | 8 | $170 |
| Alkermes, Inc. | 13 | $163 |
| Axsome Therapeutics, Inc. | 4 | $96 |
Products named: REXULTI, VRAYLAR, INGREZZA, AUSTEDO XR, COBENFY, CAPLYTA, ARISTADA, INVEGA SUSTENNA.
Industry payments across OH — which companies pay providers there.
